<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01809561</url>
  </required_header>
  <id_info>
    <org_study_id>MMC13186-12CTIL</org_study_id>
    <nct_id>NCT01809561</nct_id>
  </id_info>
  <brief_title>Telomeres Evaluation in Endometriosis</brief_title>
  <official_title>Telomeres Evaluation in Endometriosis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Meir Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Meir Medical Center</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of the study is to assess the telomere array of different endometriosis tissue
      and endometrium from women with endometriosis compared to healthy women.

      Our hypothesis is that telomere shortening and high telomerase activity will be found in
      tissues from women with endometriosis.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The purpose of the study is to assess the telomere array of different endometriosis tissue
      and endometrium from women with endometriosis compared to healthy women. Our hypothesis is
      that telomere shortening and high telomerase activity will be found in tissues from women
      with endometriosis, compared to women without endometriosis.

      A prospective study that compares telomeres and telomerase levels in different lesions of
      endometriosis and endometrial tissue of women with endometriosis and healthy women without
      endometriosis. The study group will consist of women with suspected endometriosis facing
      surgical treatment and the control group will consist of healthy women facing gynecologic
      surgery for different indication.

      We will sample endometrial tissue in both groups. In the study group we additionally will
      sample endometriosis lesion.

      The samples collected will test for histological diagnosis of endometriosis and verification
      tests will be done to characterize the telomeres array and telomerase levels and other
      characteristics for genomic instability such as spontaneous aneuploidy.

      expect telomere shortening and high telomerase activity in endometrial tissue and in
      endometriosis tissue sample, that won't characterize samples from women without
      endometriosis.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Not yet recruiting</last_known_status>
  <start_date>May 2013</start_date>
  <completion_date type="Anticipated">February 2015</completion_date>
  <primary_completion_date type="Anticipated">February 2015</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case Control</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <target_duration>6 Weeks</target_duration>
  <primary_outcome>
    <measure>characterize the telomeres array and telomerase levels and other characteristics for genomic instability such as spontaneous aneuploidy in endometriosis tissue.</measure>
    <time_frame>the tissue sample will colect at time of surgery</time_frame>
  </primary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">30</enrollment>
  <condition>Endometriosis</condition>
  <arm_group>
    <arm_group_label>endometriosis</arm_group_label>
    <description>The study group will consist of women with suspected endometriosis facing surgical treatment</description>
  </arm_group>
  <arm_group>
    <arm_group_label>no endometriosis</arm_group_label>
    <description>The control group will consist of healthy women facing gynecologic surgery for different indication</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>tissue biopsy during surgical treatment</intervention_name>
    <description>The samples collected will test for histological diagnosis of endometriosis and verification tests will be done to characterize the telomeres array and telomerase levels and other characteristics for genomic instability such as spontaneous aneuploidy.</description>
    <arm_group_label>endometriosis</arm_group_label>
    <arm_group_label>no endometriosis</arm_group_label>
    <other_name>endometriosis tissue biopsy only study group</other_name>
    <other_name>endometrial tissue biopsy</other_name>
  </intervention>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      whole blood, endometrial tissue biopsy, lesion of endometriosis
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        women facing surgical treatment
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  women with suspected endometriosis facing surgical treatment

        Exclusion Criteria:

          -  no endometriosis on histology

          -  malignant finding on histology
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>15 Years</minimum_age>
    <maximum_age>60 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Ron Schonman, DR</last_name>
    <role>Study Chair</role>
    <affiliation>MeirMc, Israel</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Merav Sharvit, DR</last_name>
    <phone>972-9-7472561</phone>
    <email>merav.sharvit@gmail.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>OBGYN department, Meir Medical Center</name>
      <address>
        <city>Kfar-Saba</city>
        <country>Israel</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Merav Sharvit, DR</last_name>
      <email>merav.sharvit@gmail.com</email>
    </contact>
    <investigator>
      <last_name>Merav Sharvit, DR</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Israel</country>
  </location_countries>
  <reference>
    <citation>Sampson JA. Metastatic or Embolic Endometriosis, due to the Menstrual Dissemination of Endometrial Tissue into the Venous Circulation. Am J Pathol. 1927 Mar;3(2):93-110.43.</citation>
    <PMID>19969738</PMID>
  </reference>
  <reference>
    <citation>Lapp T. ACOG issues recommendations for the management of endometriosis. American College of Obstetricians and Gynecologists. Am Fam Physician. 2000 Sep 15;62(6):1431, 1434.</citation>
    <PMID>11011865</PMID>
  </reference>
  <reference>
    <citation>Wells M. Recent advances in endometriosis with emphasis on pathogenesis, molecular pathology, and neoplastic transformation. Int J Gynecol Pathol. 2004 Oct;23(4):316-20. Review.</citation>
    <PMID>15381900</PMID>
  </reference>
  <reference>
    <citation>Sharpe-Timms KL. Endometrial anomalies in women with endometriosis. Ann N Y Acad Sci. 2001 Sep;943:131-47. Review.</citation>
    <PMID>11594534</PMID>
  </reference>
  <reference>
    <citation>Nolan CM. Human immunodeficiency syndrome-associated tuberculosis: a review with an emphasis on infection control issues. Am J Infect Control. 1992 Feb;20(1):30-4. Review.</citation>
    <PMID>1554145</PMID>
  </reference>
  <reference>
    <citation>Jones RK, Searle RF, Bulmer JN. Apoptosis and bcl-2 expression in normal human endometrium, endometriosis and adenomyosis. Hum Reprod. 1998 Dec;13(12):3496-502.</citation>
    <PMID>9886539</PMID>
  </reference>
  <reference>
    <citation>Meresman GF, Vighi S, Buquet RA, Contreras-Ortiz O, Tesone M, Rumi LS. Apoptosis and expression of Bcl-2 and Bax in eutopic endometrium from women with endometriosis. Fertil Steril. 2000 Oct;74(4):760-6.</citation>
    <PMID>11020520</PMID>
  </reference>
  <reference>
    <citation>Higashiura Y, Kajihara H, Shigetomi H, Kobayashi H. Identification of multiple pathways involved in the malignant transformation of endometriosis (Review). Oncol Lett. 2012 Jul;4(1):3-9. Epub 2012 Apr 23.</citation>
    <PMID>22807950</PMID>
  </reference>
  <reference>
    <citation>Amiel A, Gronich N, Yukla M, Suliman S, Josef G, Gaber E, Drori G, Fejgin MD, Lishner M. Random aneuploidy in neoplastic and pre-neoplastic diseases, multiple myeloma, and monoclonal gammopathy. Cancer Genet Cytogenet. 2005 Oct 1;162(1):78-81.</citation>
    <PMID>16157205</PMID>
  </reference>
  <reference>
    <citation>Amiel A, Yukla M, Gaber E, Leopold L, Josef G, Fejgin M, Lishner M. Random aneuploidy in CML patients at diagnosis and under imatinib treatment. Cancer Genet Cytogenet. 2006 Jul 15;168(2):120-3.</citation>
    <PMID>16843101</PMID>
  </reference>
  <reference>
    <citation>Saini N, Srinivasan R, Chawla Y, Sharma S, Chakraborti A, Rajwanshi A. Telomerase activity, telomere length and human telomerase reverse transcriptase expression in hepatocellular carcinoma is independent of hepatitis virus status. Liver Int. 2009 Sep;29(8):1162-70. doi: 10.1111/j.1478-3231.2009.02082.x. Epub 2009 Jul 17.</citation>
    <PMID>19627485</PMID>
  </reference>
  <reference>
    <citation>Svenson U, Roos G. Telomere length as a biological marker in malignancy. Biochim Biophys Acta. 2009 Apr;1792(4):317-23. doi: 10.1016/j.bbadis.2009.01.017. Epub 2009 Feb 7. Review.</citation>
    <PMID>19419696</PMID>
  </reference>
  <reference>
    <citation>Yokoyama Y, Takahashi Y, Morishita S, Hashimoto M, Niwa K, Tamaya T. Telomerase activity in the human endometrium throughout the menstrual cycle. Mol Hum Reprod. 1998 Feb;4(2):173-7.</citation>
    <PMID>9542976</PMID>
  </reference>
  <reference>
    <citation>Lehner R, Enomoto T, McGregor JA, Shroyer AL, Haugen BR, Pugazhenthi U, Shroyer KR. Quantitative analysis of telomerase hTERT mRNA and telomerase activity in endometrioid adenocarcinoma and in normal endometrium. Gynecol Oncol. 2002 Jan;84(1):120-5.</citation>
    <PMID>11748987</PMID>
  </reference>
  <reference>
    <citation>Kim CM, Oh YJ, Cho SH, Chung DJ, Hwang JY, Park KH, Cho DJ, Choi YM, Lee BS. Increased telomerase activity and human telomerase reverse transcriptase mRNA expression in the endometrium of patients with endometriosis. Hum Reprod. 2007 Mar;22(3):843-9. Epub 2006 Oct 31.</citation>
    <PMID>17077107</PMID>
  </reference>
  <reference>
    <citation>Hapangama DK, Turner MA, Drury JA, Quenby S, Saretzki G, Martin-Ruiz C, Von Zglinicki T. Endometriosis is associated with aberrant endometrial expression of telomerase and increased telomere length. Hum Reprod. 2008 Jul;23(7):1511-9. doi: 10.1093/humrep/den172. Epub 2008 May 2.</citation>
    <PMID>18456668</PMID>
  </reference>
  <reference>
    <citation>Halme J, Hammond MG, Hulka JF, Raj SG, Talbert LM. Retrograde menstruation in healthy women and in patients with endometriosis. Obstet Gynecol. 1984 Aug;64(2):151-4.</citation>
    <PMID>6234483</PMID>
  </reference>
  <verification_date>February 2013</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 10, 2013</study_first_submitted>
  <study_first_submitted_qc>March 10, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 12, 2013</study_first_posted>
  <last_update_submitted>April 7, 2013</last_update_submitted>
  <last_update_submitted_qc>April 7, 2013</last_update_submitted_qc>
  <last_update_posted type="Estimate">April 9, 2013</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>endometriosis</keyword>
  <keyword>telomere</keyword>
  <keyword>telomerase</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Endometriosis</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

